Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death‐1 monoclonal antibodies for advanced melanoma

Overview of attention for article published in Asia Pacific Journal of Clinical Oncology, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 572)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 88 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 118 X posts from 88 X users, with an upper bound of 389,629 followers.

Clinical and palliative care outcomes for melanoma patients treated with anti-PD1 https://t.co/C57XbNxglf We found that people with poor performance status did poorly and more likely to die in hospital #anzspm2022

02 Sep 2022

Reply Repost Favourite

RT @DrPeterLau: @drcbsteer @anmwongNZ showed similarly poor outcomes for patients with ECOG 2/3 performance status treated with anti-PD1 mo…

08 Jun 2021

Reply Repost Favourite

@drcbsteer @anmwongNZ showed similarly poor outcomes for patients with ECOG 2/3 performance status treated with anti-PD1 monotherapy several years ago. https://t.co/G7ohlLBFJQ. Same finding now just with combo

06 Jun 2021

Reply Repost Favourite

RT @fischmd: @ramsedhom @tmprowell @IshwariaMD @mtmdphd @montypal @oncology_bg @guptaarjun90 Poor performance status is associated with wor…

20 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 114 additional X posts.